Product Information

FEBUXOSTAT 40 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2114 per EA under NDC 47335072183. Its NADAC has been published 362 times since Sep 18, 2019.

FDA first approved this application on Jul 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FEBUXOSTAT 40 MG TABLET

Febuxostat
$0.2114per EA

Strength

40 mg/1

NDC

47335072183

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

FEBUXOSTAT

Approval Type

Generic (ANDA)

FDA Application

ANDA205467

FDA Approved

7/1/2019

TE Code

AB

On Market Since

7/5/2019

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for FEBUXOSTAT 40 MG TABLET has been published 362 times since Sep 18, 2019, and over the history we have for it it has declined 97.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2114 per EA
All-time high$6.9447 (Oct 16, 2019)
All-time low$0.2016 (Jan 21, 2026)
52-week high$0.2818
52-week low$0.2016
Median price$0.6455
Average price$1.1551
Largest weekly change-33.0% (Apr 22, 2020)
Weeks tracked362
Tracking sinceSep 18, 2019

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

+4.3%

1Y

-25.0%

3Y

-69.4%

5Y

-80.3%

All

-97.0%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FEBUXOSTAT 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 40 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.2114 per EA (NDC 47335072183), effective Aug 19, 2026.

How has the price of FEBUXOSTAT 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for FEBUXOSTAT 40 MG TABLET has declined 97.0%. It has been tracked across 362 weekly CMS publications since Sep 18, 2019.

What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 40 MG TABLET?

Since Sep 18, 2019, the NADAC for FEBUXOSTAT 40 MG TABLET has ranged from a low of $0.2016 (Jan 21, 2026) to a high of $6.9447 (Oct 16, 2019), with a median of $0.6455 per EA.

Are there cheaper alternatives to FEBUXOSTAT 40 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FEBUXOSTAT 40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FEBUXOSTAT 40 MG TABLET?

FEBUXOSTAT 40 MG TABLET (NDC 47335072183) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.